Turner et al., 2002 - Google Patents
Specificity of memapsin 1 and its implications on the design of memapsin 2 (β-secretase) inhibitor selectivityTurner et al., 2002
View PDF- Document ID
- 3264412906170615118
- Author
- Turner R
- Loy J
- Nguyen C
- Devasamudram T
- Ghosh A
- Koelsch G
- Tang J
- Publication year
- Publication venue
- Biochemistry
External Links
Snippet
Memapsin 1 is closely homologous to memapsin 2 (BACE), or β-secretase, whose action on β-amyloid precursor protein (APP) leads to the production of β-amyloid (Aβ) peptide and the progression of Alzheimer's disease. Memapsin 2 is a current target for the development of …
- 102100015650 BACE1 0 title abstract description 216
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Turner et al. | Specificity of memapsin 1 and its implications on the design of memapsin 2 (β-secretase) inhibitor selectivity | |
| Turner et al. | Subsite specificity of memapsin 2 (β-secretase): implications for inhibitor design | |
| Altalhi et al. | PAI-1 in diabetes: pathophysiology and role as a therapeutic target | |
| Mitsudo et al. | Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis | |
| Pallares et al. | Structure of human carboxypeptidase A4 with its endogenous protein inhibitor, latexin | |
| Paul et al. | Natural Catalytic Antibodies: Peptide-hydrolyzing Activities of Bence Jones Proteins and VL Fragment (∗) | |
| Labat-de-Hoz et al. | Formins in human disease | |
| Wen et al. | The plasma and cytoplasmic forms of human gelsolin differ in disulfide structure | |
| Van den Steen et al. | Generation of glycosylated remnant epitopes from human collagen type II by gelatinase B | |
| Luque et al. | Molecular basis of resistance to HIV-1 protease inhibition: a plausible hypothesis | |
| Kurochkin et al. | Toward allosterically increased catalytic activity of insulin-degrading enzyme against amyloid peptides | |
| Kong et al. | Copper binding to the Alzheimer’s disease amyloid precursor protein | |
| Yuan et al. | A selective activity-based probe for the papain family cysteine protease dipeptidyl peptidase I/cathepsin C | |
| Ghosh et al. | Design, synthesis and X-ray structure of protein− ligand complexes: Important insight into selectivity of memapsin 2 (β-Secretase) inhibitors | |
| Oliveira et al. | Isomannide-based peptidomimetics as inhibitors for human tissue kallikreins 5 and 7 | |
| García Díaz et al. | Ca2+ dependency of calpain 3 (p94) activation | |
| Jia et al. | Mutations in calpain 3 associated with limb girdle muscular dystrophy: analysis by molecular modeling and by mutation in m-calpain | |
| Kallergi et al. | Targeting and maturation of Erv1/ALR in the mitochondrial intermembrane space | |
| Hruz et al. | Cysteine-scanning mutagenesis of transmembrane segment 11 of the GLUT1 facilitative glucose transporter | |
| Wlodawer et al. | Inhibitor complexes of the Pseudomonas serine-carboxyl proteinase | |
| McGrath et al. | Crystal structure of phenylmethanesulfonyl fluoride-treated human chymase at 1.9 Å | |
| Kornacker et al. | An inhibitor binding pocket distinct from the catalytic active site on human β-APP cleaving enzyme | |
| Pop et al. | Mutations in the procaspase-3 dimer interface affect the activity of the zymogen | |
| Radisky et al. | Binding, proteolytic, and crystallographic analyses of mutations at the protease− inhibitor interface of the subtilisin BPN ‘/chymotrypsin inhibitor 2 complex | |
| Stanley et al. | Amino acids responsible for reduced affinities of vitamin K-dependent propeptides for the carboxylase |